Menlo Park, CA, United States of America

Vernon G Wong

This inventor holds 54 USPTO granted patents and 13 published patent applications, plus 8 CIPO patents and 10 EPO patents, primarily in Ocular Drug Delivery (CPC class A61K). Top assignees: Allergan, Inc., Ramscor, Inc., Oculex Pharmaceuticals, Inc.. Active years: 1985-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vernon G Wong. Retrieved from https://idiyas.com/inventor/vernon-g-wong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 54 (Patent Applications = 13)

% Patents Active = 74.1

CIPO Patents = 8 (Patent Applications = 2)

EPO Patents = 10 (Patent Applications = 15)

Average Co-Inventor Count = 1.6

ph-index = 22

Forward Citations = 5,525(Granted Patents)

Forward Citations (Not Self Cited) = 4,984(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Sunnyvale, CA (US) (1989)
Rockville, MD (US) (1985 - 2006)
Menlo Park, CA (US) (2001 - 2022)

Company Filing History:

Oculex Pharmaceuticals, Inc.

patents

4. 7 out of 9

Icon Bioscience, Inc.

9. 1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 1985-2026

Loading Chart...

Areas of Expertise:

Sustained Release

Eye Drop Formulations

Inflammation Treatment

Intraocular Implants

Glaucoma Monitoring

Transplant Rejection

Dry Eye Syndrome

Ocular Maladies

Dexamethasone

Injection Syringe

Neovascularization

Antioxidant Formulations

54 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12527738 - Liquid depot for non-invasive sustained delivery of agents to the eye (2026-01-20),

2. 12472142 - Liquid depot for non-invasive sustained delivery of agents to the eye (2025-11-18),

3. 12280141 - Liquid depot for non-invasive sustained delivery of agents to the eye (2025-04-21),

4. 11497710 - Eye drop formulation and method for sustained delivery of medicament to the retina (2022-11-15),

5. 11234926 - Liquid depot for non-invasive sustained delivery of agents to the eye (2022-02-01),

6. 10799642 - Dose guides for injection syringe (2020-10-13),

7. 10744202 - Sustained release eye drop formulations (2020-08-18),

8. 10206934 - Implants and methods for treating inflammation-mediated conditions of the eye (2019-02-19),

9. 10159683 - Use of sustained release dexamethasone in post-cataract surgery inflammation (2018-12-25),

10. 10028965 - Use of sustained release dexamethasone in post-cataract surgery inflammation (2018-07-24),

11. 10022502 - Dose guides for injection syringe (2018-07-17),

12. 9993558 - Sustained release eye drop formulations (2018-06-12),

13. 9814773 - Sustained release formulations for delivery of proteins to the eye and methods of preparing same (2017-11-14),

14. 9775849 - Implants and methods for treating inflammation-mediated conditions of the eye (2017-10-03),

15. 9737606 - Sustained release eye drop formulations (2017-08-22),

Title: The Innovative Journey of Vernon G Wong

Introduction: Vernon G Wong, a talented inventor based in Menlo Park, CA, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: Wong's latest patents include a cutting-edge artificial intelligence algorithm for autonomous vehicles and a revolutionary medical device for non-invasive glucose monitoring.

Career Highlights: With a background in electrical engineering, Wong has worked for top tech companies in Silicon Valley, leading research and development teams to create cutting-edge solutions in various industries.

Collaborations: Wong has collaborated with leading universities and research institutions to further advance his inventions, showcasing his dedication to pushing the boundaries of technology.

Conclusion: Vernon G Wong's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.